|Articles|October 1, 2016
- Applied Clinical Trials-10-01-2016
- Volume 25
- Issue 10
Applied Clinical Trials, October/November 2016 Issue (PDF)
Click the title above to open the Applied Clinical Trials October/November 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
PDUFA VI Promotes Patient Views, Innovative Trialsalmost 10 years ago
Health Technology Assessment: Europe Peers Into the Mistalmost 10 years ago
Europe’s New Clinical Trials Landscape Looms Largealmost 10 years ago
Best Practices in Study Feasibilityalmost 10 years ago
FDA Includes First PRO Measure for COPDalmost 10 years ago
The Growth of Direct-to-Patient Trialsalmost 10 years ago
It’s Never Too Early for Cold Chain Planning for Cell Therapiesalmost 10 years ago
Finally, Standardized KPIs are Front and Centeralmost 10 years ago
Assessing Global Clinical Supply Logisticsalmost 10 years ago
6 Ways to Protect the Blind in Clinical TrialsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
2
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
3
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
4
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
5